Skip to main content
Premium Trial:

Request an Annual Quote

BioReference Laboratories' Q4 Revenues Climb 18 Percent

NEW YORK (GenomeWeb) – BioReference Laboratories announced today that its fourth quarter revenues increased 18 percent year over year with the number of patients served jumping 9 percent.

The Elmwood Park, NJ-based clinical lab firm reported revenues of $227.6 million for its fiscal fourth quarter ended Oct. 31, up from $192.2 million for the fourth quarter of 2013.

The number of patients served grew to 2,550 in the quarter from 2,350 in Q4 2013, while revenue per patient increased 10 percent year over year to $88.67 from $80.80.

BRL posted net income of $18.3 million, or $.66 per share, for the quarter, compared to $11.1 million, or $.40 per share, for Q4 2013.

For FY 2014, BRL reported total revenues of $832.3 million, up 16 percent from $715.4 million in FY 2013. Its net income for the year was $46.8 million, or $1.68 per share, compared to $45.8 million, or $1.65 per share, for FY 2013.

BRL finished its fiscal year with $17.5 million in cash and cash equivalents.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.